You just read:

Ascendis Pharma A/S Announces Positive Interim Results from a Phase 2 Pediatric Study of Once-Weekly TransCon Growth Hormone for the Treatment of Growth Hormone Deficiency

News provided by

Ascendis Pharma A/S

16 Sep, 2014, 13:27 BST